Jason Cohen

About the Author Jason Cohen

Jason is a Smarter Analyst editor and writer, who specializes in biotech and cannabis-based pharmaceutical companies.

Evolus (EOLS) Stock Just Got a Major Face-Lift; Mizuho Analyst Weighs In

Congrats. Evolus (EOLS) is the first company to win FDA approval for a neurotoxin that is considered biosimilar to branded Botox for the …

Teva Stock Gets a Thumbs Up from Merrill Lynch Ahead of Earnings

The turnaround at Teva Pharmaceutical Industries (TEVA) remains on schedule. Investors appear satisfied that CEO Kare Schultz is making enough progress in battling …

Why BioLineRx (BLRX) Stock Spiked Today

A journey of a thousand miles begins with a single step, and a big one in this case. BioLineRx (BLRX) announced this morning that …

Aphria (APHA): Analyst Shares Two Cents on Green Growth Formal Offer

With cannabis legitimized, a number of clearly defined trends have emerged. For instance, dealmaking has been on the rise and acquisitions have picked up.

Piper Jaffray Pounds the Table on Canopy Growth (CGC) Stock

With Canada rolling out the red carpet for cannabis, a handful of pot stocks have emerged as potential winners in the eyes of …

Amarin (AMRN): New Survey Offers Insight Into Vascepa Market Opportunity

Amarin’s (AMRN) Vascepa is currently approved to treat around 3.8 million Americans with high triglycerides, as an adjunct to diet.

Is It Too Late to Join the OncoCyte (OCX) Stock Party? Analyst Weighs In

Investors love healthcare stocks for the lottery ticket-like returns they can offer if a company strikes medical gold. Case in point: Shares of …

Should You Buy Amarin (AMRN) Stock? 4 Pros, 4 Cons

Year-to-date, Amarin (AMRN) stock is up nearly 20% due to Pfizer buyout chatter. According to rumors, the pharma giant is interested in making …

Spooked Investors Send ResMed (RMD) Stock Spiraling; Analysts Weigh In

Send ResMed (RMD) shares tanked nearly 18% today, leaving investors at odds over when it will hit a bottom. What’s causing investors to hit …

Avalon Globocare (AVCO) Stock: The Wolf of Wall Street?

Low-priced biotech stocks are often targets of pump-and-dump manipulation scams or other activity designed to make money for a select few, not you …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts